Trends in Extracorporeal Membrane Oxygenation for the Treatment of Acute Respiratory Distress Syndrome in the United States

Journal of Intensive Care Medicine

Volumn 32, Issue 9, 2017, Pages 535-539

  Rush, Barret ^a,b   Wiskar, Katie ^a   Berger, Landon ^a   Griesdale, Donald ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

ECMO; epidemiology; hospital mortality; respiratory failure

Indexed keywords

NITRIC OXIDE;

ACUTE RESPIRATORY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CHRONIC RESPIRATORY FAILURE; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; FEMALE; HOSPITAL DISCHARGE; HOSPITAL MORTALITY; HUMAN; ICD-9; LENGTH OF STAY; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; TERTIARY CARE CENTER; TREATMENT DURATION; UNITED STATES; AGED; EVALUATION STUDY; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TREATMENT OUTCOME; TRENDS;

ADULT; AGED; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT DISCHARGE; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84977164239     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066616631956     Document Type: Article

References (28)

1. Ferguson ND, Fan E, Camporota L, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012; 38 (10): 1573-1582.
2. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005; 353 (16): 1685-1693.
3. Rubenfeld GD, Herridge MS,. Epidemiology and outcomes of acute lung injury. Chest. 2007; 131 (2): 554-562.
4. Zambon M, Vincent JL,. Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest. 2008; 133 (5): 1120-1127.
5. Phua J, Badia JR, Adhikari NKJ, et al. Has mortality from acute respiratory distress syndrome decreased over time?: a systematic review. Am J Respir Crit Care Med. 2009; 179 (3): 220-227.
6. Villar J, Blanco J, Añón JM, et al. The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med. 2011; 37 (12): 1932-1941.
7. Guérin C, Reignier J, Richard J-C, et al.PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013; 368 (23): 2159-2168.
8. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000; 342 (18): 1301-1308.
9. Papazian L, Forel JM, Gacouin A, et al.ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010; 363 (12): 1107-1116.
10. Extracorporeal Life Support Organization. Guidelines for Adult Respiratory Failure [Internet]. 2013. Web site. https://www.elso.org/Portals/0/IGD/Archive/FileManager/989d4d4d14cusersshyerdocumentselsoguidelinesforadultrespiratoryfailure1.3.pdf. Accessed February 1, 2016.
11. Tramm R, Ilic D, Davies AR, Pellegrino VA, Romero L, Hodgson C,. Extracorporeal membrane oxygenation for critically ill adults. Cochrane Database Syst Rev. 2015; 1: cd010381.
12. Paden ML, Conrad SA, Rycus PT, Thiagarajan RR, ELSO Registry. Extracorporeal Life Support Organization Registry Report 2012. ASAIO J. 2013; 59 (3): 202-210.
13. Vandenbroucke JP, von Elm E, Altman DG, et al.STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007; 18 (6): 805-835.
14. Reynolds H, McCunn M, Borg U, Habashi N, Cottingham C, Bar-Lavi Y,. Acute respiratory distress syndrome: estimated incidence and mortality rate in a 5 million-person population base. Crit Care. 1998; 2 (1): 29-34.
15. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, Davies A, Jones D, Bailey M, et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA. 2009; 302 (17): 1888-1895.
16. Zangrillo A, Biondi-Zoccai G, Landoni G, et al. Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO. Crit Care. 2013; 17 (1): r30.
17. Combes A,. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome (EOLIA TRIAL) Clinical Trials Number NCT01470703 [Internet]. 2015. Web site. https://clinicaltrials.gov/show/NCT01470703. Accessed February 1, 2016.
18. Mitchell MD, Mikkelsen ME, Umscheid CA, Lee I, Fuchs BD, Halpern SD,. A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. Crit Care Med. 2010; 38 (6): 1398-1404.
19. Munshi L, Telesnicki T, Walkey A, Fan E,. Extracorporeal life support for acute respiratory failure. A systematic review and metaanalysis. Ann Am Thorac Soc. 2014; 11 (5): 802-810.
20. Schmidt M, Hodgson C, Combes A,. Extracorporeal gas exchange for acute respiratory failure in adult patients: a systematic review. Crit Care. 2015; 19: 99.
21. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009; 374 (9698): 1351-1363.
22. Del Sorbo L, Cypel M, Fan E,. Extracorporeal life support for adults with severe acute respiratory failure. Lancet Respir Med. 2014; 2 (2): 154-164.
23. Roch A, Hraiech S, Masson E, et al. Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center. Intensive Care Med. 2014; 40 (1): 74-83.
24. Schmidt M, Bailey M, Sheldrake J, et al. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med. 2014; 189 (11): 1374-1382.
25. Park PK, Dalton HJ, Bartlett RH,. Point: Efficacy of extracorporeal membrane oxygenation in 2009 influenza A(H1N1): sufficient evidence? Chest. 2010; 138 (4): 776-778.
26. Morris AH, Hirshberg E, Miller RR III, Statler KD, Hite RD,. Counterpoint: Efficacy of extracorporeal membrane oxygenation in 2009 influenza A(H1N1): sufficient evidence? Chest. 2010; 138 (4): 778-781; discussion 782-784.
27. Sidebotham D,. Extracorporeal membrane oxygenation - understanding the evidence: CESAR and beyond. J Extra Corpor Technol. 2011; 43 (1): p23-26.
28. Francois G,. Strategy of UltraProtective Lung Ventilation With Extracorporeal CO2 Removal for New-Onset Moderate to seVere ARDS (SUPERNOVA) [Internet]. 2015. Web site. https://clinicaltrials.gov/ct2/show/NCT02282657. Accessed February 1, 2016.